Mikael Åberg
Researcher at Department of Medical Sciences; Clinical Biomarkers Facility
- Telephone:
- +46 18 471 44 10
- E-mail:
- Mikael.Aberg@medsci.uu.se
- Visiting address:
- BMC, D11:208B, Husargatan 3
752 37 Uppsala - Postal address:
- C/O BMC Intendenturen
Affinity Proteomics Uppsala, Box 570
751 23 Uppsala
Associate professor at Department of Medical Sciences; Cardiology
- Telephone:
- +46 18 471 44 10
- E-mail:
- mikael.aberg@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA - Postal address:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA
Download contact information for Mikael Åberg at Department of Medical Sciences; Cardiology

Publications
Selection of publications
-
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
Part of The Lancet Microbe, 2023
-
Next generation pan-cancer blood proteome profiling using proximity extension assay
Part of Nature Communications, 2023
- DOI for Next generation pan-cancer blood proteome profiling using proximity extension assay
- Download full text (pdf) of Next generation pan-cancer blood proteome profiling using proximity extension assay
-
SARS-CoV-2-related mortality decrease in nursing home residents given multiple COVID-19 boosters
Part of The Lancet - Infectious diseases, 2023
-
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
Part of The Lancet - Infectious diseases, p. 150-152, 2023
-
Mucosal IgA protects against BQ.1 and BQ.1.1 infection
Part of The Lancet - Infectious diseases, 2023
-
Part of Nature Communications, 2023
- DOI for Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
- Download full text (pdf) of Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
-
Part of Journal of Clinical Immunology, p. 1075-1082, 2023
- DOI for SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants
- Download full text (pdf) of SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants
-
Part of EBioMedicine, 2023
- DOI for Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID
- Download full text (pdf) of Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID
-
Part of New Biotechnology, p. 139-148, 2022
- DOI for Detection of SARS-CoV-2 antibodies in serum and dried blood spot samples of vaccinated individuals using a sensitive homogeneous proximity extension assay
- Download full text (pdf) of Detection of SARS-CoV-2 antibodies in serum and dried blood spot samples of vaccinated individuals using a sensitive homogeneous proximity extension assay
-
Periodontal Disease Augments Cardiovascular Disease Risk Biomarkers in Rheumatoid Arthritis
Part of Biomedicines, 2022
- DOI for Periodontal Disease Augments Cardiovascular Disease Risk Biomarkers in Rheumatoid Arthritis
- Download full text (pdf) of Periodontal Disease Augments Cardiovascular Disease Risk Biomarkers in Rheumatoid Arthritis
-
Part of Clinical and Translational Gastroenterology, 2022
-
Part of Platelets, p. 1199-1207, 2022
- DOI for Platelet-leukocyte aggregate formation and inflammation in patients with pulmonary arterial hypertension and CTEPH
- Download full text (pdf) of Platelet-leukocyte aggregate formation and inflammation in patients with pulmonary arterial hypertension and CTEPH
-
Part of Vaccines, 2022
- DOI for Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
- Download full text (pdf) of Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
-
Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.
Part of Cancers, 2022
- DOI for Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.
- Download full text (pdf) of Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.
-
Part of The Lancet - Infectious diseases, p. 943-945, 2022
-
Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time
Part of Clinical & Translational Immunology (CTI), 2022
- DOI for Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time
- Download full text (pdf) of Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time
-
Part of Journal of Internal Medicine, p. 72-80, 2022
- DOI for Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19
- Download full text (pdf) of Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19
-
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
Part of New England Journal of Medicine, p. 1333-1336, 2022
-
Part of Journal of Thrombosis and Haemostasis, p. 2726-2737, 2021
- DOI for Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
- Download full text (pdf) of Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
-
Part of PLoS Medicine, 2021
- DOI for Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
- Download full text (pdf) of Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
-
Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients
Part of Cytokine, 2021
- DOI for Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients
- Download full text (pdf) of Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients
-
Part of EBioMedicine, 2021
- DOI for Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
- Download full text (pdf) of Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
-
Part of Arteriosclerosis, Thrombosis and Vascular Biology, p. 2293-2309, 2020
-
Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival
Part of Apoptosis (London), p. 519-534, 2020
- DOI for Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival
- Download full text (pdf) of Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival
-
Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
Part of Upsala Journal of Medical Sciences, p. 238-245, 2019
-
Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner
Part of Upsala Journal of Medical Sciences, p. 158-167, 2019
- DOI for Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner
- Download full text (pdf) of Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner
-
Part of Thrombosis and Haemostasis open, 2018
-
Part of Cardiovascular Research, 2018
-
Activation of beta1-integrins and caveolin-1 by TF/FVIIa promotes cell survival
Part of Cardiovascular Research, 2018
-
Part of Cardiovascular Research, 2018
-
Proteomic, functional and receptor studies of growth differentiation factor 15, GDF-15
Part of Cardiovascular Research, 2018
-
Part of Thrombosis and Haemostasis, p. 1379-1390, 2017
-
Tissue factor/FVIIa transactivates the IGF-1R by a Src-dependent phosphorylation of caveolin-1
Part of Cardiovascular Research, 2016
-
Tissue factor/FVIIA transactivates the IGF-1R in prostate cancer cells via inhibition of caveolin-1
Part of Journal of Thrombosis and Haemostasis, p. 707-707, 2015
-
Tissue Factor Noncoagulant Signaling: Mechanisms and Implications for Cell Migration and Apoptosis
Part of Seminars in Thrombosis and Hemostasis, p. 691-699, 2015
-
Part of Thrombosis and Haemostasis, p. 748-760, 2014
-
Part of Journal of Thrombosis and Haemostasis, p. 817-825, 2013
-
The insulin-like growth factor 1 receptor mediates tissue factor/FVIIa-induced cell survival
Part of Journal of Thrombosis and Haemostasis, p. 171-172, 2013
-
A quantitative real-time PCR method for tissue factor mRNA
Part of Thrombosis Research, p. 175-83, 2003
-
Recent publications
-
Part of Scientific Reports, 2026
- DOI for Vaccination-first immune priming shapes a sustained mRNA vaccine-induced IgG4 class switch that associates with SARS-CoV-2 breakthrough infection risk
- Download full text (pdf) of Vaccination-first immune priming shapes a sustained mRNA vaccine-induced IgG4 class switch that associates with SARS-CoV-2 breakthrough infection risk
-
Inflammatory protein profiles and shunt response in iNPH
Part of Fluids and Barriers of the CNS, 2026
- DOI for Inflammatory protein profiles and shunt response in iNPH
- Download full text (pdf) of Inflammatory protein profiles and shunt response in iNPH
-
Part of eBioMedicine, 2026
-
Part of eBioMedicine, 2026
- DOI for Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunity
- Download full text (pdf) of Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunity
-
Part of BMC Medicine, 2026
- DOI for Serological evidence of substantial respiratory syncytial virus infection burden among older adults residing in Swedish long-term care facilities
- Download full text (pdf) of Serological evidence of substantial respiratory syncytial virus infection burden among older adults residing in Swedish long-term care facilities
All publications
Articles in journal
-
Part of Scientific Reports, 2026
- DOI for Vaccination-first immune priming shapes a sustained mRNA vaccine-induced IgG4 class switch that associates with SARS-CoV-2 breakthrough infection risk
- Download full text (pdf) of Vaccination-first immune priming shapes a sustained mRNA vaccine-induced IgG4 class switch that associates with SARS-CoV-2 breakthrough infection risk
-
Inflammatory protein profiles and shunt response in iNPH
Part of Fluids and Barriers of the CNS, 2026
- DOI for Inflammatory protein profiles and shunt response in iNPH
- Download full text (pdf) of Inflammatory protein profiles and shunt response in iNPH
-
Part of eBioMedicine, 2026
-
Part of eBioMedicine, 2026
- DOI for Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunity
- Download full text (pdf) of Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunity
-
Part of BMC Medicine, 2026
- DOI for Serological evidence of substantial respiratory syncytial virus infection burden among older adults residing in Swedish long-term care facilities
- Download full text (pdf) of Serological evidence of substantial respiratory syncytial virus infection burden among older adults residing in Swedish long-term care facilities
-
Part of Vaccine, 2025
- DOI for Comparing methods collecting mucosal secretions and detecting SARS-CoV-2 spike IgA in three laboratories across three countries
- Download full text (pdf) of Comparing methods collecting mucosal secretions and detecting SARS-CoV-2 spike IgA in three laboratories across three countries
-
Part of eBioMedicine, 2025
- DOI for Impact of systemic SARS-CoV-2 vaccination on mucosal IgA responses to subsequent breakthrough infection
- Download full text (pdf) of Impact of systemic SARS-CoV-2 vaccination on mucosal IgA responses to subsequent breakthrough infection
-
Plasma protein profiling predicts cancer in patients with non-specific symptoms
Part of Nature Communications, 2025
- DOI for Plasma protein profiling predicts cancer in patients with non-specific symptoms
- Download full text (pdf) of Plasma protein profiling predicts cancer in patients with non-specific symptoms
-
Part of International Journal of Molecular Sciences, 2025
- DOI for Mapping Interactions Between Cytokines, Chemokines, Growth Factors, and Conventional Biomarkers in COVID-19 ICU-Patients
- Download full text (pdf) of Mapping Interactions Between Cytokines, Chemokines, Growth Factors, and Conventional Biomarkers in COVID-19 ICU-Patients
-
Part of Communications Chemistry, 2025
- DOI for Comparative evaluation of Olink Explore 3072 and mass spectrometry with peptide fractionation for plasma proteomics
- Download full text (pdf) of Comparative evaluation of Olink Explore 3072 and mass spectrometry with peptide fractionation for plasma proteomics
-
Part of European Archives of Psychiatry and Clinical Neuroscience, p. 1453-1464, 2025
- DOI for A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon Europe
- Download full text (pdf) of A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon Europe
-
Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study
Part of Scandinavian Journal of Gastroenterology, p. 597-605, 2025
- DOI for Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study
- Download full text (pdf) of Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study
-
Part of Inflammation, p. 760-769, 2025
- DOI for Plasma H3Cit-DNA Discriminates Between Cancer and Inflammation in a Cohort of Patients with Unspecific Cancer Symptoms
- Download full text (pdf) of Plasma H3Cit-DNA Discriminates Between Cancer and Inflammation in a Cohort of Patients with Unspecific Cancer Symptoms
-
Part of Frontiers in Cellular and Infection Microbiology, 2025
- DOI for Plasma protein biomarkers of Plasmodium falciparum infection in pregnant women: a high-throughput proteomics study
- Download full text (pdf) of Plasma protein biomarkers of Plasmodium falciparum infection in pregnant women: a high-throughput proteomics study
-
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden
Part of The Lancet - Infectious diseases, p. 80-81, 2024
-
Part of EBioMedicine, 2024
- DOI for Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID
- Download full text (pdf) of Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID
-
Part of Scientific Reports, 2024
- DOI for Monitoring SARS-CoV-2 IgA, IgM and IgG antibodies in dried blood and saliva samples using antibody proximity extension assays (AbPEA)
- Download full text (pdf) of Monitoring SARS-CoV-2 IgA, IgM and IgG antibodies in dried blood and saliva samples using antibody proximity extension assays (AbPEA)
-
Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023
Part of The Lancet Regional Health, 2024
- DOI for Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023
- Download full text (pdf) of Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023
-
Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum
Part of Frontiers in Immunology, 2024
- DOI for Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum
- Download full text (pdf) of Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum
-
Part of Haematologica, p. 646-651, 2024
- DOI for Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia
- Download full text (pdf) of Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia
-
Part of The Lancet Regional Health, 2023
- DOI for Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study
- Download full text (pdf) of Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study
-
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
Part of The Lancet Microbe, 2023
-
Next generation pan-cancer blood proteome profiling using proximity extension assay
Part of Nature Communications, 2023
- DOI for Next generation pan-cancer blood proteome profiling using proximity extension assay
- Download full text (pdf) of Next generation pan-cancer blood proteome profiling using proximity extension assay
-
SARS-CoV-2-related mortality decrease in nursing home residents given multiple COVID-19 boosters
Part of The Lancet - Infectious diseases, 2023
-
Part of PLOS ONE, 2023
- DOI for Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
- Download full text (pdf) of Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
-
Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection
Part of New England Journal of Medicine, p. 1626-1628, 2023
-
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
Part of The Lancet - Infectious diseases, p. 150-152, 2023
-
Mucosal IgA protects against BQ.1 and BQ.1.1 infection
Part of The Lancet - Infectious diseases, 2023
-
Part of Journal of Hematology, p. 170-175, 2023
- DOI for Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia
- Download full text (pdf) of Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia
-
Part of Nature Communications, 2023
- DOI for Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
- Download full text (pdf) of Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
-
Part of Journal of Clinical Immunology, p. 1075-1082, 2023
- DOI for SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants
- Download full text (pdf) of SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants
-
Part of EBioMedicine, 2023
- DOI for Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID
- Download full text (pdf) of Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID
-
Part of New Biotechnology, p. 139-148, 2022
- DOI for Detection of SARS-CoV-2 antibodies in serum and dried blood spot samples of vaccinated individuals using a sensitive homogeneous proximity extension assay
- Download full text (pdf) of Detection of SARS-CoV-2 antibodies in serum and dried blood spot samples of vaccinated individuals using a sensitive homogeneous proximity extension assay
-
Periodontal Disease Augments Cardiovascular Disease Risk Biomarkers in Rheumatoid Arthritis
Part of Biomedicines, 2022
- DOI for Periodontal Disease Augments Cardiovascular Disease Risk Biomarkers in Rheumatoid Arthritis
- Download full text (pdf) of Periodontal Disease Augments Cardiovascular Disease Risk Biomarkers in Rheumatoid Arthritis
-
Part of Clinical and Translational Gastroenterology, 2022
-
Part of Platelets, p. 1199-1207, 2022
- DOI for Platelet-leukocyte aggregate formation and inflammation in patients with pulmonary arterial hypertension and CTEPH
- Download full text (pdf) of Platelet-leukocyte aggregate formation and inflammation in patients with pulmonary arterial hypertension and CTEPH
-
Part of Vaccines, 2022
- DOI for Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
- Download full text (pdf) of Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
-
Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.
Part of Cancers, 2022
- DOI for Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.
- Download full text (pdf) of Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.
-
Part of The Lancet - Infectious diseases, p. 943-945, 2022
-
Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time
Part of Clinical & Translational Immunology (CTI), 2022
- DOI for Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time
- Download full text (pdf) of Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time
-
Part of Journal of Internal Medicine, p. 72-80, 2022
- DOI for Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19
- Download full text (pdf) of Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19
-
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
Part of New England Journal of Medicine, p. 1333-1336, 2022
-
Part of Journal of Thrombosis and Haemostasis, p. 2726-2737, 2021
- DOI for Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
- Download full text (pdf) of Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
-
Part of PLoS Medicine, 2021
- DOI for Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
- Download full text (pdf) of Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
-
Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients
Part of Cytokine, 2021
- DOI for Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients
- Download full text (pdf) of Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients
-
Part of EBioMedicine, 2021
- DOI for Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
- Download full text (pdf) of Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
-
Part of Arteriosclerosis, Thrombosis and Vascular Biology, p. 2293-2309, 2020
-
Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival
Part of Apoptosis (London), p. 519-534, 2020
- DOI for Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival
- Download full text (pdf) of Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival
-
Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
Part of Upsala Journal of Medical Sciences, p. 238-245, 2019
-
Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner
Part of Upsala Journal of Medical Sciences, p. 158-167, 2019
- DOI for Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner
- Download full text (pdf) of Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner
-
Part of Thrombosis and Haemostasis open, 2018
-
Part of Cardiovascular Research, 2018
-
Activation of beta1-integrins and caveolin-1 by TF/FVIIa promotes cell survival
Part of Cardiovascular Research, 2018
-
Part of Cardiovascular Research, 2018
-
Proteomic, functional and receptor studies of growth differentiation factor 15, GDF-15
Part of Cardiovascular Research, 2018
-
Part of Thrombosis and Haemostasis, p. 1379-1390, 2017
-
Tissue factor/FVIIa transactivates the IGF-1R by a Src-dependent phosphorylation of caveolin-1
Part of Cardiovascular Research, 2016
-
Tissue factor/FVIIA transactivates the IGF-1R in prostate cancer cells via inhibition of caveolin-1
Part of Journal of Thrombosis and Haemostasis, p. 707-707, 2015
-
Tissue Factor Noncoagulant Signaling: Mechanisms and Implications for Cell Migration and Apoptosis
Part of Seminars in Thrombosis and Hemostasis, p. 691-699, 2015
-
Part of Thrombosis and Haemostasis, p. 748-760, 2014
-
Part of Journal of Thrombosis and Haemostasis, p. 817-825, 2013
-
The insulin-like growth factor 1 receptor mediates tissue factor/FVIIa-induced cell survival
Part of Journal of Thrombosis and Haemostasis, p. 171-172, 2013
-
A quantitative real-time PCR method for tissue factor mRNA
Part of Thrombosis Research, p. 175-83, 2003